Quality-of-Life Outcomes, Effectiveness and Tolerability of Apremilast in Patients with Plaque Psoriasis and Routine German Dermatology Care: Results from LAPIS-PSO

INTRODUCTION: Psoriasis is a systemic inflammatory disease characterised by pruritic skin lesions that impair quality of life (QOL). Long-Term Documentation of the Utilization of Apremilast in Patients with Plaque Psoriasis under Routine Conditions (LAPIS-PSO; ClinicalTrials.gov: NCT02626793) was a...

Descripción completa

Detalles Bibliográficos
Autores principales: Reich, Kristian, Korge, Bernhard, Magnolo, Nina, Manasterski, Maria, Schwichtenberg, Uwe, Staubach-Renz, Petra, Kaiser, Stephan, Roemmler-Zehrer, Josefine, Gómez, Natalie Núnez, Lorenz-Baath, Katrin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8776950/
https://www.ncbi.nlm.nih.gov/pubmed/34913153
http://dx.doi.org/10.1007/s13555-021-00658-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8776950/
https://www.ncbi.nlm.nih.gov/pubmed/34913153
http://dx.doi.org/10.1007/s13555-021-00658-x

Ejemplares similares